4A7C-301
Based on 1 publication(s) in Google Scholar
4A7C-301 is a blood-brain barrier-permeable Nurr1 agonist, with IC50 values of 48.22 nM and 107.71 nM for binding to Nurr1-LBD in the [3H]-CQ competition assay and TR-FRET assay, respectively. The EC50 of 4A7C-301 for activating Nurr1 transcriptional activity is 6.53 μM, and its EC50 in N27-A dopaminergic cells is approximately 0.2 μM. 4A7C-301 binds directly to Nurr1-LBD, enhances the transcriptional function of Nurr1, and restores the reduction of Nurr1 protein induced by MPP+ or αSyn. 4A7C-301 alleviates oxidative stress and mitochondrial dysfunction, protects midbrain dopaminergic neurons, inhibits microglial activation, and restores impaired autophagic flux. 4A7C-301 can be used in studies related to neuroprotection and Parkinson's disease.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.86%
- CAS. Nr.: 3137918-83-0
- Formel: C27H38ClN9
- Molecular Weight:524.10
-
Speicherung:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) 4A7C-301
MoreAlle Nuclear Hormone Receptor 4A/NR4A Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
Nurr1 6.53 μM (EC50) |
Nurr1-LBD 48.22 nM (IC50, [3H]-CQ competition assay) |
In Vitro
4A7C-301 binds directly to Nurr1-LBD, with IC50 values of 48.22 ± 22.05 nM and 107.71 ± 14.14 nM in the [3H]-CQ competition assay and TR-FRET competition assay, respectively[1].
4A7C-301 activates the transcriptional activity of Nurr1 with an EC50 of 6.53 μM and a maximum induction fold of 18.12-fold, and exhibits an EC50 of approximately 0.2 μM in N27-A dopaminergic cells[1].
4A7C-301 (5-1000 nM; 30 min pre-treatment) exerts a dose-dependent protective effect on TH+ dopaminergic neurons against MPP+ (0.5 μM)- or LPS (HY-D1056) (15 ng/mL)-induced injury in primary rat VM neuron-glia co-cultures, with the maximal neuroprotective effect observed at 500 nM after 7 days of treatment[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:N27-A cells with Nurr1 OE or KD
-
Concentration:4A7C-301: 1 μM; MPP+: 1 mM
-
Incubation Time:Overnight
-
Result:Increased cell viability in a Nurr1-dependent manner.
In Vivo
4A7C-301 (5 mg/kg/day; i.p.; daily; 5 weeks) ameliorates neuropathological abnormalities, improves motor and olfactory dysfunctions, and restores dopamine levels in both αSynWT- and αSynA53T-overexpressing male mice with greater potency than CQ[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 J (male, 8-10 weeks old, 25-30 g, subchronic MPTP-induced Parkinson’s disease model)[1]
-
Dosage:5 mg/kg/day
-
Administration:i.p.; daily; 16 days
-
Result:Rescued MPTP-induced motor deficits in rotarod, pole, and cylinder tests to a degree comparable to higher doses of CQ and L-DOPA.
Restored olfactory dysfunction impaired by MPTP lesion.
Detected no abnormal involuntary movements (AIMs, dyskinesia-like behaviors).
Significantly retained tyrosine hydroxylase-positive (TH+) fibers in the striatum, TH+ dopamine neurons, and NeuN+ neurons in the substantia nigra compared to MPTP-only group.
Significantly reduced Iba-1+ activated microglia in both the striatum and substantia nigra.
Restored dopamine levels in both the striatum and substantia nigra.
-
Animal Model:C57BL/6 J (male, 8-10 weeks old, 25-30 g, AAV2-mediated wild-type α-synuclein and mutant α-synuclein overexpression Parkinson’s disease model)[1]
-
Dosage:5 mg/kg/day
-
Administration:i.p.; daily; 5 weeks
-
Result:Improved motor deficits in cylinder, rotarod, and pole tests with greater potency than CQ in both αSynWT- and αSynA53T-induced mice.
Rescued olfactory dysfunction in both αSynWT- and αSynA53T-induced mice.
Significantly prevented the loss of TH+ and NeuN+ neurons in the substantia nigra and TH+ fibers in the striatum in both αSynWT- and αSynA53T-induced mice.
Significantly reduced phosphorylated αSyn at serine 129 (αSynS129) in both αSynWT- and αSynA53T-induced mice.
Restored dopamine levels in both the striatum and substantia nigra in both models.
Chemical Information
-
CAS. Nr. 3137918-83-0
-
Appearance Solid
-
Molecular Weight 524.10
-
Formel C27H38ClN9
-
Color White to light yellow
-
SMILES
ClC1=CC=C2C(NCCNC3=NC(N4CCN(CC)CC4)=CC(N5CCN(CC)CC5)=N3)=CC=NC2=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
J Med Chem
Comparative Profiling and Chemogenomics Application of Chemical Tools for NR4A Nuclear Receptors. [Abstract]2025 Oct 9;68(19):19955-19970. PMID: 40968635
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 140 mg/mL (267.12 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Protokoll
-
Dual Luciferin reporter gene assay
Luciferin reporter gene assay is a reporting system to detect the activity of Firefly Luciferase using luciferin as a substrate, which is often used in the research of miRNA target gene verification and promoter transcriptive activity regulation. Dual luciferase usually refers to Firefly luciferase and Renilla luciferase.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Human pluripotent stem cell midbrain dopaminergic neuron differentiation
Human pluripotent stem cells are directed toward midbrain dopaminergic neurons by first inducing a neural floor-plate-like progenitor state, then patterning cells with ventralizing SHH signaling and midbrain/WNT-FGF cues, and finally maturing progenitors into neurons expressing dopaminergic markers such as TH, NURR1/NR4A2, PITX3, DAT/SLC6A3, VMAT2/SLC18A2, GIRK2/KCNJ6, FOXA2, LMX1A, and EN1. The main readouts are loss of pluripotency, acquisition of FOXA2+/LMX1A+ midbrain floor-plate progenitors, emergence of βIII-tubulin+/MAP2+ neurons, and production of TH+ dopaminergic neurons with molecular, dopamine-release, and electrophysiological features of midbrain dopaminergic identity.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Reinheit & Dokumentation
-
Data Sheet (291 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9080 mL | 9.5402 mL | 19.0803 mL | 47.7008 mL |
| 5 mM | 0.3816 mL | 1.9080 mL | 3.8161 mL | 9.5402 mL | |
| 10 mM | 0.1908 mL | 0.9540 mL | 1.9080 mL | 4.7701 mL | |
| 15 mM | 0.1272 mL | 0.6360 mL | 1.2720 mL | 3.1801 mL | |
| 20 mM | 0.0954 mL | 0.4770 mL | 0.9540 mL | 2.3850 mL | |
| 25 mM | 0.0763 mL | 0.3816 mL | 0.7632 mL | 1.9080 mL | |
| 30 mM | 0.0636 mL | 0.3180 mL | 0.6360 mL | 1.5900 mL | |
| 40 mM | 0.0477 mL | 0.2385 mL | 0.4770 mL | 1.1925 mL | |
| 50 mM | 0.0382 mL | 0.1908 mL | 0.3816 mL | 0.9540 mL | |
| 60 mM | 0.0318 mL | 0.1590 mL | 0.3180 mL | 0.7950 mL | |
| 80 mM | 0.0239 mL | 0.1193 mL | 0.2385 mL | 0.5963 mL | |
| 100 mM | 0.0191 mL | 0.0954 mL | 0.1908 mL | 0.4770 mL |